{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-24-000082","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.181960+00:00","generated_at":"2026-06-04T02:24:02.778632+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Clover Health resolves derivative suits; $2.5M counsel fees, governance changes","bullets":["Settlement requires no monetary payment to shareholders; $2.5M in fees to plaintiffs' counsel subject to court approval.","Company must implement corporate governance enhancements as part of settlement.","Court preliminarily approved settlement on March 5, 2024; final approval hearing set for July 11, 2024.","Derivative actions stemmed from Hindenburg Research allegations and 2021 de-SPAC merger."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-24-000082","json":"https://secwatch.observer/filing/0001801170-24-000082.json","markdown":"https://secwatch.observer/filing/0001801170-24-000082.md","text":"https://secwatch.observer/filing/0001801170-24-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000082/0001801170-24-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000082/clov-20240404.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:24:02.778632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}